Fund HoldingsSaturn V Capital Management LP

Total Portfolio Value
$261.25M
Total Bought
$58.36M
Total Sold
$93.18M
Net Transaction
-$34.82M
Filing Period:
Securities
SharesValue ($K)
Q3 2023
Q4 2023
Change
Q3 2023
Q4 2023
Weight (%)
Change
CYTOKINETICS INC(CYTK)495,168448,144-47,02414,58837,41614.32%+22,828
ARGENX SE(ARGX)10,07451,175+41,1014,95319,4697.45%+14,516
MERUS N V40,066389,333+349,26794510,7074.10%+9,762
APELLIS PHARMACEUTICALS INC
COM
0142,927+142,92708,5563.27%+8,556
ASCENDIS PHARMA A/S(ASND)112,473131,759+19,28610,53216,5956.35%+6,063
KALVISTA PHARMACEUTICALS INC1,810,2461,807,563-2,68317,43322,1438.48%+4,710
ANAPTYSBIO INC577,101664,276+87,17510,36514,2295.45%+3,864
DISC MEDICINE INC(IRON)064,784+64,78403,7421.43%+3,742
MORPHIC HLDG INC136,743212,343+75,6003,1336,1322.35%+3,000
AMICUS THERAPEUTICS INC
COM
0199,973+199,97302,8381.09%+2,838
ALNYLAM PHARMACEUTICALS INC(ALNY)010,327+10,32701,9770.76%+1,977
BIOMARIN PHARMACEUTICAL INC(BMRN)109,685119,188+9,5039,70511,4924.40%+1,787
PHATHOM PHARMACEUTICALS INC(PHAT)0160,075+160,07501,4610.56%+1,461
CYMABAY THERAPEUTICS INC1,124,459750,250-374,20916,76617,7216.78%+955
AMBRX BIOPHARMA INC052,781+52,78107520.29%+752
JASPER THERAPEUTICS INC1,387,0151,386,215-8009711,0940.42%+123
AMYLYX PHARMACEUTICALS INC(AMLX)886,1431,099,268+213,12516,22516,1816.19%-44
SYNDAX PHARMACEUTICALS INC(SNDX)807,969518,799-289,17011,73211,2114.29%-520
ASTRIA THERAPEUTICS INC1,219,093990,663-228,4309,0947,6082.91%-1,486
ITEOS THERAPEUTICS INC994,756828,232-166,52410,8939,0693.47%-1,823
CRINETICS PHARMACEUTICALS IN(CRNX)1,126,579787,132-339,44733,50428,00610.72%-5,498
BIOCRYST PHARMACEUTICALS INC(BCRX)982,4580-982,4586,9560-6,956
BIOGEN INC(BIIB)64,67632,469-32,20716,6228,4023.22%-8,220
HORIZON THERAPEUTICS PUB L111,0450-111,04512,8470-12,847
COGENT BIOSCIENCES INC(COGT)1,775,415756,681-1,018,73417,3104,4491.70%-12,861
SAREPTA THERAPEUTICS INC(SRPT)118,4010-118,40114,3530-14,353
Page 1 of 1